prof. dr. R.A. (Robert) Schoevers

PhD projects, with expected/realised year of promotion

Version: Jan 2026

1. Jolien Veraart; ketamine for depression; mechanisms, RUG, 1st promotor (2026)
2. Astrid Lugtenburg; depression and cognitive decline RUG, 2nd promotor (2026)
3. David Wedema; Storytelling and Training to Advance Individual Recovery Skills, RUG, 1st promotor (2026)
4. Gerben Ruesink; the pleasure circle; a neurobiological view, 1st promotor, (2026)
5. Annemiek Kamstra: Is residential dialectical behaviour therapy and prolonged exposure (DBT-PE) (cost)effective for patients with severe PTSD and co-morbid (personality)disorders?, RUG, 1st promotor (2026)
6. Jurriaan Strous: ketamine for suicidality; markers and mechanisms (2026)
7. Gijs Roelandt: ketamine for suicidality; clinical aspects (2027)
8. Nina Schimmers: psychedelics for end of life distress (2027)
9. Martijn Godschalk: oral esketamine versus ECT for patients with treatment resistant depression (2027)
10. Rosalie Fleurbaaij: oral esketamine versus ECT for patients with treatment resistant depression (2027)
11. Juliana Lima Constantino; using real world data to improve the outcome of depression treatments (2027)
12. Sara Massetti: mechanisms of antidepressant treatment, a cross-species perspective (2028)
13. Juliana Dean: predicting the course of depression in clinical care (2028)
14. Rutger Boesjes: sleep and depression; clinical and preclinical studies (2028).
15. Stephan Tap: psychedelic assisted treatment for end-of-life distress (2028)
16. Akib Khan: mechanisms of psychedelic-assisted treatments (2029)
17. Mike Jentsch: Advancing the diagnosis of major depressive disorder by adding a biological perspective: key considerations for developing a biomarker panel for MDD, RUG, 1st promotor (2025)
18. Sanne Apeldoorn Oral esketamine for difficult-to-treat depression RUG, 1st promotor (2025) (cum laude)
19. Celien Tigchelaar: Liquid gold: Cerebrospinal fluid collection, composition and biomarkers, RUG, 2nd promotor (2025)
20. Joost Breeksema: Exploring inner depths: a qualitative investigation of patients lived experiences with psychedelic treatments of depression RUG, 1st promotor (2024)
21. Stella Druiven Chronotype, depression, and circadian treatment strategies: Bridging the gap between epidemiology and clinical practice RUG, 1st promotor (2025)
22. Lino von Klipstein The experience sampling method in mental health care: integrating research and practice RUG, 2nd promotor (2024)
23. Julian Burger: the future of case formulation in clinical psychology, RUG, 2nd promotor, 2023 (cum laude)
24. Ernst Horwitz Boundaries, transitions: Autism Spectrum Disorder in adolescents and adults RUG, 2nd promotor, 2023
25. Madelien van de Beek Mental health problems in Moroccan-Dutch people: a mixed-methods study into social determinants, experiences and explanations RUG, 1st promotor, 2022
26. Date van der Veen Anxiety in late-life depression RUG, 2nd promotor, 2022
27. Kaying Kan Going beyond cost-effectiveness: analyzing routine mental healthcare data and stakeholders perspectives to improve depression care RUG, 1st promotor, 2021
28. Anouk de Wit Can hormones get you down? studies on sex steroids and depression RUG, 1st promotor, 2021 (cum laude)
29. Lian Beijers Parsing the heterogeneity of Major Depression: Biological subtyping and other statistical approaches to unravel the causes of Major Depression RUG, 1st promotor, 2021
30. Iris Jonker Inflammation as a transdiagnostic factor in the development of psychopathology and somatic symptoms RUG, 1st promotor, 2021
31. Petra Havinga; Breaking the cycle? intergenerational transmission of depression/anxiety and opportunities for interventions RUG, 1st promotor, 2020
32. Dennis Raven; Wheres the need? the use of specialist mental health services in adolescence and young adulthood RUG, 2nd promotor, 2020
33. Hanneke Geugies Learning from reward and prediction: insights in mechanisms related to recurrence vulnerability and non-response in depression RUG, 1st promotor, 2020
34. Ella Bekhuis A body-mind map: epidemiological and clinical aspects of the relation between somatic, depressive and anxiety symptomatology RUG, 2nd promotor, 2020 (cum laude)
35. Ans Hovenkamp-Hermelink The long-term course of anxiety disorders: An epidemiological perspective RUG, 1st promotor, 2020
36. Stefan Knapen Rhythm & Blues RUG, 1st promotor, 2019
37. Anne van Gils Developing e-health applications to promote a patient-centered approach to medically unexplained symptoms RUG, 2nd promotor, 2019
38. Huifang Yin Epidemiology and treatment of mental disorders in a rapidly developing urban region in China: a study of prevalence, risk factors and e-applications RUG, 1st promotor, 2019
39. Chengao Yang An inflamed mood: studies on the role of inflammation in the pathophysiology and treatment outcome of major depressive disorder, RUG, 1st promotor, 2019
40. Claudia van Borkulo  Symptom network models in depression research RUG, 1st promotor, 2018 (cum laude)
41. Marije Swets Obsessive compulsive symptoms in psychotic disorders UVA Amsterdam, 2nd promotor, 2018
42. Mia Scheffers; Body image, psychopathology and psychomotor therapy 2018 RUG, 1st promotor.
43. Karlijn Becking MDD, Bipolar depression and inflammatory dysregulation RUG, 1st promotor, 2018
44. Katelijne van Emmerik – van Oortmerssen ADHD and Substance Use Disorder RUG, 1st promotor, 2018
45. Sjoerd van Belkum; Neuromodulation and depression RUG, 1st promotor, 2018
46. Anne Looijmans; Lifestyle interventions in psychiatry RUG, 1st promotor, 2018
47. Mirjam Simoons Monitoring Outcomes of Psychiatric Pharmacotherapy (MOPHAR) RUG, 2nd promotor, 2018
48. Koen Hogenelst Serotonin manipulations and social behavior RUG, 2nd promotor, 2017
49. Erin van Buel Towards a neurobiological view of depression RUG, 2nd promotor, 2017
50. Tjalling Holwerda Loneliness, depression and mortality Amsterdam VU, 1st promotor, 2017
51. Hanna van Loo; Data-driven subtypes of major depressive disorder, RUG, 1st promotor, 2015 (cum laude)
52. Radboud Marijnissen The weight of subclinical vascular disease & neuroticism in late-life depression, RUG, 2nd promotor, 2014
53. Marrit de Boer Antipsychotic treatment and sexual functioning: From mechanisms to clinical practice RUG, 1st promotor, 2014
54. Nadine Troquete START-ing Risk Assessment and Shared Care Planning in Out-patient Forensic Psychiatry.: Results from a cluster randomized controlled trial RUG, 2nd promotor, 2014
55. Jaap Peen Mental health and urbanization: An investigation of urban-rural and innner-city differences in psychiatric morbidity Amsterdam VU, copromotor, 2009
56. Henricus Van Exploring predictive factors in the treatment of major depression Amsterdam VU, copromotor, 2008
57. Saskia de Maat On the effectiveness of psychoanalytic psychotherapy Amsterdam VU, copromotor, 2007  
58. Simone Kool Comorbidity of Major Depression and Personality Disorders Amsterdam UVA, copromotor, 2005